Pancreatic Cancer Research

ResearcherBritish Columbia Institute of TechnologyNo recent work listed

David Hasman

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5051950934. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 3

  1. Devil's Club Falcarinol-Type Polyacetylenes Inhibit Pancreatic Cancer Cell Proliferation. First author DOI 10.1080/01635581.2018.1559931↗
  2. Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's Club Oplopanax horridus and Its Polyacetylene Bioactive Compound. Co-author DOI 10.1080/01635581.2015.1055367↗
  3. Antiproliferation activity of Devil's club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids. Last author DOI 10.1016/j.phymed.2013.10.003↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph Tai · 3 shared papers, 2014–2019 · strength 0.23
  2. Garth L. Warnock · 3 shared papers, 2014–2019 · strength 0.23
  3. Susan S. C. Cheung · 2 shared papers, 2015–2019 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.